E-poster No. / 壁報編號
C37
Title / 題目
Effectiveness and safety of ribociclib versus palbociclib as first-line therapy in metastatic breast cancer: a target trial emulation using real-world data
First Author / 第一作者
Cho-Hao, Lee
Institution / 單位
¹Tri-service General Hospital, Department of Internal Medicine, Division of Hematology and Oncology, National Defense Medical University
²Tri-service General Hospital, Department of Oncology, National Defense Medical University
Audio / 音訊檔
Author Group / 作者群
¹Tri-service General Hospital, Department of Internal Medicine, Division of Hematology and Oncology, National Defense Medical University
²Tri-service General Hospital, Department of Oncology, National Defense Medical University
Author Group Institution/ 作者群單位
¹Tri-service General Hospital, Department of Internal Medicine, Division of Hematology and Oncology, National Defense Medical University
²Tri-service General Hospital, Department of Oncology, National Defense Medical University
Category / 主題分類
Clinical Research
Keyword / 關鍵字
Metastatic breast cancer CDK4/6 inhibitors Ribociclib Palbociclib Hormone receptor-positive Overall survival Real-world data Target trial emulation Comparative effectiveness